Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.61 USD | +2.74% | +4.74% | +33.89% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.89% | 2.32B | |
+12.55% | 3,096B | |
+12.96% | 85.37B | |
+7.73% | 77.1B | |
-13.71% | 54.31B | |
-22.64% | 47.92B | |
+25.54% | 47.74B | |
+21.49% | 42.15B | |
+70.17% | 38.06B | |
-8.47% | 24.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Reports Q3 Revenue $84.2M, vs. Street Est of $82.1M